  See all
 |
Articles: BMT/SCT |
Prior Articles
Bortezomib, tacrolimus and methotrexate for prophylaxis of graft-versus-host-disease after reduced-intensity conditioning allogeneic stem cell transplantation from HLA-mismatched unrelated donors
Blood, 08/28/09
Loss of the Rho GTPase activating protein p190-B enhances hematopoietic stem cell engraftment potential
Blood, 08/28/09 Preengraftment Syndrome after Unrelated Cord Blood Transplant Is a Strong Predictor of Acute and Chronic Graft-versus-Host Disease
Biology of Blood and Marrow Transplantation, 08/28/09 Allogeneic haemopoietic stem cell transplantation in children: what alternative donor should we choose when no matched sibling is available
British Journal of Haematology, 08/27/09 Successful allogeneic bone marrow transplantation for myelodysplastic syndrome complicated by severe pulmonary alveolar proteinosis
International Journal of Hematology, 08/27/09 Stable mixed donor–donor chimerism after double cord blood transplantation
International Journal of Hematology, 08/27/09 Successful treatment of young-onset adult T cell leukemia/lymphoma and preceding chronic refractory eczema and corneal injury by allogeneic hematopoietic stem cell transplantation
International Journal of Hematology, 08/27/09 Sequential Intensified Conditioning and Tapering of Prophylactic Immunosuppressants for Graft-versus-Host Disease in Allogeneic Hematopoietic Stem Cell Transplantation for Refractory Leukemia
Biology of Blood and Marrow Transplantation, 08/26/09 High risk of hepatitis B-virus reactivation after hematopoietic cell transplantation in hepatitis B core antibody-positive patients
European Journal of Haematology, 08/26/09 Second unrelated cord blood transplantation using a reduced-intensity conditioning regimen combined with gemtuzumab ozogamicin in patients with relapsed acute myelogenous leukemia
International Journal of Hematology, 08/26/09 Sibling versus Unrelated Donor Allogeneic Hematopoietic Cell Transplantation for Chronic Myelogenous Leukemia: Refined HLA Matching Reveals More Graft-versus-Host Disease but not Less Relapse
Biology of Blood and Marrow Transplantation, 08/26/09 Multivariate analyses of immune reconstitution in children after allo-SCT: risk-estimation based on age-matched leukocyte sub-populations
Bone Marrow Transplantation, 08/26/09 Second hematopoietic SCT for lymphoma patients who relapse after autotransplantation: another autograft or switch to allograft[quest]
Bone Marrow Transplantation, 08/26/09
Exclusive Author Commentary Comprehensive assessment of T cell receptor chain diversity in T cells
Blood, 08/26/09 Allogeneic Stem Cell Transplantation Is Able to Induce Long-Term Remissions in Angioimmunoblastic T-Cell Lymphoma: A Retrospective Study From the Lymphoma Working Party of the European Group for Blood and Marrow Transplantation
Journal of Clinical Oncology, 08/26/09 Peripheral blood stem cell collection in elderly patients
Annals of Hematology, 08/25/09 Post-autologous stem cell transplantation administration of rituximab improves the outcome of patients with aggressive B cell non-Hodgkin’s lymphoma
Annals of Hematology, 08/25/09 Cytotoxic T lymphocyte therapy with donor T cells prevents and treats adenovirus and Epstein-Barr virus infections after haploidentical and matched unrelated stem cell transplant
Blood, 08/25/09 Activating killer immunoglobulin-like receptor incompatibilities enhance graft-versus-host disease and affect survival after allogeneic hematopoietic stem cell transplantation
European Journal of Haematology, 08/25/09 Standard graft-versus-host disease prophylaxis with or without anti-T-cell globulin in haematopoietic cell transplantation from matched unrelated donors: A randomised, open-label, multicentre phase 3 trial
The Lancet Oncology - Online First, 08/24/09
|
|
Receive free subspecialty "5-minute updates" via email
|
|
Indexed Journals: Journal of Clinical Oncology, Cancer Research, Annals Oncology
more...
|
250 Available Pages
|
|
